AzTrials
AzTrials

Obsessive-Compulsive DisorderNCT03473080

An eHealth Intervention for Obsessive Compulsive Disorder in Youth With Autism Spectrum Disorder

A study testing Internet CBT in people with Obsessive-Compulsive Disorder, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is a feasibility study of Internet-delivered CBT for OCD in children and adolescents (7-17 years) with comorbid Autism Spectrum Disorder. Read more about this study

Who is it for?
Ages 7 to 17 years
Conditions the study is for
Obsessive-Compulsive Disorder
What is being tested?
Internet CBT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteSweden
Study dates
9 Mar 2018to 15 Feb 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • a diagnosis of OCD according to DSM-5
  • a diagnosis of autism according to DSM-IV or DSM-5, confirmed with the Autism Diagnostic Interview- Revised or Autism Diagnostic Observation Schedule version 1 or 2 and by medical records
  • a total score of ≥ 16 on the Children's Yale-Brown Obsessive-Compulsive Scale
  • age between 7 and 17 years
  • ability to read and write Swedish
  • access to the internet
  • a parent that is able to co-participate in the treatment
  • participants on psychotropic medication must have been on a stable dose for the last 6 weeks prior to baseline assessment

Who cannot join

  • a diagnosis of psychosis, bipolar disorder, severe eating disorder or intellectual disabilities
  • comorbid hoarding disorder or OCD with hoarding as a principal symptom.
  • suicidal ideation
  • subject not able to read or understand the basics of the ICBT material
  • completed CBT for OCD within last 12 months (defined as at least 5 sessions of CBT including exposure and response prevention)
  • ongoing psychological treatment for OCD or any anxiety disorder
  • OCD treatment is not an immediate priority

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • BUP OCD and Related Disorders

    Stockholm, 11330

Other trials in Sweden

About this study

Official title: Feasibility of a Therapist and Parent Guided eHealth Intervention for Obsessive Compulsive Disorder in Youth With Autism Spectrum Disorder

This study is a feasibility study of Internet-delivered CBT for OCD in children and adolescents (7-17 years) with comorbid Autism Spectrum Disorder.

Read the detailed description

The main objectives of this study is to evaluate the feasibility, acceptability and preliminary efficacy of internet-delivered Cognitive Behavioral Therapy (ICBT) for Obsessive Compulsive Disorder (OCD) in children and adolescents (7-17 years) with Autism Spectrum Disorders (ASD). The study will an open trial with-in group mean comparison design (n=18). The treatment is delivered over 16 weeks. Study participants will be followed up at 3 (primary endpoint), 6 and 12 months after completed treatment. ICBT is expected to decrease OCD-symptoms.

Being tested
Internet CBT
Keywords
OCD, ASD, Obsessive Compulsive Disorder, Autism Spectrum Disorder, ICBT, eHealth, Internet, CBT, Pediatric, Adolescents, Children, Internet-delivered
Medical subject headings
Obsessive-Compulsive Disorder, Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet CBTBehavioural

    Also called ICBT, Internet-delivered Cognitive Behavior Therapy

    The treatment consists of a standard cognitive behavior therapy for OCD with additional treatment components to make the treatment better suited for children and adolescents with Autism Spectrum Disorder.

Study groups in NCT03473080
Study groupRoleWhat they receive
Internet CBTOtherParticipants and their parents receive 16 weeks of internet-delivered cognitive behavior therapy (CBT) with psychologist support.
Receives: Behavioral: Internet CBT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Children's Yale-Brown Obsessive Compulsive Scale

    Changein obsessions and compulsions will be measured as the total score on the scale.. Total score ranges from 0 to 40 points, a higher score indicates more severe OCD. The scale is rated by a clinician.

    Measured: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

Secondary outcomes (17)
  1. Obsessive-compulsive inventory - child version

    Child-rating of OCD symptoms. The total score range is 0-42, a higher score indicates more OCD-symptoms.

    Measured: Baseline, weekly during treatment, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  2. Autism spectrum quotient (AQ-10)

    Parent-rated, brief screeing for symtoms relating to autism spectrum disorder. Total score ranges from 0-10, a higher score indicating more symtoms.

    Measured: Baseline

  3. Education, work and social adjustment scale - child and parent version

    Self-rated and parent-rated. Ranges from 0 to 40 points, a higher score indicating more problems. Measures how much the psychiatric problems affect daily life in different areas.

    Measured: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  4. Family accommodation scale for obsessive-compulsive disorder

    Parent-rated scale, total score ranges from 0 to 76, a higher score indicates more family accommodation to the child's OCD.

    Measured: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  5. Mood and Feeling Questionnaire - child and parent version

    Self-rated and parent-rated. Measures depressive symptoms in the child. Total score ranges from 0 to 26, a higher score indicates more depressive symptoms.

    Measured: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  6. Children's Obsessional Compulsive Inventory Revised - parent rated (ChOCI-R-P)

    Parent-rated. Consists of 4 Subscales. Obsessive symptoms, Compulsive symtoms, Obsessive impairment and Compulsive impairment. The symptom subscales range from 10 to 30 points, a higher score indicating more symptomology. These subscales are added to get a total score for OCD-symptoms. The score of each impairment subscales ranges from 0 to 24, a higher score indicating more impairment. The score of the impairment subscales are added to get a total score of impairment. The symptom subscales will only be administered at baseline. The impairment subscales will be administered at all assessment points.

    Measured: Baseline, weekly during treatment, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  7. Mini International Neuropsychiatric Interview for Children and Adolescents

    Clinician-rated, a semi-structured interview to asses psychiatric problems in children. Results will be presented as co-morbid psychiatric diagnoses.

    Measured: Baseline

  8. Children's global assessment scale

    Clinician-rated, measures the childs global psychiatric functioning. Total score ranges from 0-100, a lower score indicates lower functioning.

    Measured: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  9. Children's Assessment Scale for Developmental Disabilities

    Clinician-rated. measures the childs global functioning with respect to developmental disabilities. Total score ranges from 0 to 100, a lower score indicates lower functioning.

    Measured: Baseline

  10. Clinical global impression - severity

    Clinician-rated level of psychiatric severity, the score ranges from 1 to 7, a lower score indicates less severity. In this study the measure will only refer to level of OCD.

    Measured: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  11. Clinical global impression - improvement

    Clinician-rated level of psychiatric improvement, the score ranges from 1 to 7, a lower score indicates more improvement. In this study the measure will only refer to level of OCD.

    Measured: 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment

  12. internet intervention Patient Adherence Scale

    Clinician-rated, measures the patients adherence to treatment. The scale consist of 5 items measuring 1. If the patient is in phase with treatment, 2, level of engagement in treatment 3, level of communication with the clinician, 4 motivation to change 5, frequency of log-ins to the internet-treatment. Total score ranges from 0 to 20, a higher score indicates more adherence to the treatment.

    Measured: 8 weeks, 16 weeks

  13. Client Satisfaction Questionnaire (CSQ-8)

    Self-rated and parent-rated. Measures level of satisfaction with the treatment. Total score ranges from 8 to 32, higher level indicates higher satisfaction.

    Measured: 16 weeks

  14. Parent strategies

    A parent-rated questionnaire consisting of 4 items measuring the parents 1, participation in treatment, 2, cooperation with the child during treatment, 3, autonomus support in treatment and 4, directiveness in treatment. The questions are qualitative and results will be presented on an item level

    Measured: Post-treatment

  15. Patient EX/RP Adherence Scale

    Self-rated questionnaire. Consist of 3 items: 1, percentage of attempted exposure exercises, 2, how well exposures were performed and 3, percentatge of respons-prevention during the last week. The answers will be presented on an item level.

    Measured: Weekly for 16 weeks (during treatment)

  16. Drop-out rate from treatment

    Percentage of patients that drop out from ICBT

    Measured: at week 16

  17. Completed treatment modules

    Number of completed treatment modules

    Measured: week 16

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2018
  2. Study start9 Mar 2018
  3. Primary completion15 Feb 2021
  4. Study completion15 Feb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03473080
Sponsor's protocol ID
BIP ASD/OCD pilot
Status last verified
Jul 2021
First submitted
16 Feb 2018
Last updated
6 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Internet CBT in people with Obsessive-Compulsive Disorder, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Children's Yale-Brown Obsessive Compulsive Scale (time frame: Baseline, 16 weeks (= post treatment), 3 months after post treatment, 6 months after post treatment, 12 months after post treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in